Stocks · News reference
Filed: 2026-10-13 AccNo: 0000950157-26-001098 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
H. B. Fuller reported Q3 2026 earnings of $1.52 per share, beating consensus estimates of $1.45, with revenues of $938.18 million slightly exceeding expectations. However, the stock has underperformed the market by 14.1% year-to-date and carries a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends. The company's near-term outlook remains uncertain despite solid earnings performance.
--- Company reiterates long-term targets and highlights value creation opportunities --- --- Presents capability to produce high-purity calcium metal to support domestic heavy rare earth metallization ------ Reveals a
Analysts downgraded XENE, NFLX and MGA, while raising price targets for OCS, INSW, ABEO and STNG.